Lisa M Jarvis is a Pharma Columnist at Bloomberg News. She specializes in drug discovery, rare diseases, and the intersection of science and business, often sharing her insights on R&D and the impact of Covid-19. Her work has been featured in various prominent publications, highlighting her expertise and unique opinions in the pharmaceutical industry.
Preston's Summary
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Geo Focus
United States (National)
Coverage Attributes:
Beta
Government Announcement:
40
%
Legal Policy Regulation:
20
%
Opinion Editorial:
20
%
Cites Data:
20
%
Themes Covered:
Not enough data
Most Recent Topics:
Not enough data
Pitching Insights
Lisa M Jarvis’s reporting largely revolves around healthcare and pharmaceuticals, with a strong emphasis on data-driven insights. She frequently cites data in her articles, indicating an interest in evidence-based approaches.
Given the breadth of topics covered within healthcare and pharmaceuticals, Lisa may be open to pitches from experts who can provide compelling data-driven analysis or perspectives on current trends related to youth mental health, infant health, alcohol consumption, obesity management, abortion access issues,sickle cell disease treatment,and pandemic-related stress.
As she does not have a specific geographic focus mentioned and has covered diverse healthcare topics like maternal health and drug pricing alongside other themes such as flu vaccines,cancer treatments,and cholesterol; sources should ensure their expertise aligns with the specific topic being pitched rather than focusing solely on location-specific insights.
This information evolves through artificial intelligence and human feedback. Improve this profile .
